Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cytokine ; 158: 155970, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-35917725

RESUMO

BACKGROUND: There are no major tools that could predict disease severity in COVID-19. The aim of this study is to evaluate if serum galectin-3 levels can identify disease progression in COVID-19. METHODS: Patients that were hospitalized due to COVID-19 between March and June 2020 were included in this cross-sectional prospective study. Baseline demographic and clinical data in addition to levels of serum parameters including galectin-3 were measured at the time of hospital admission. Patients with COVID-19 were categorized into two groups (non-severe and severe illness). The need for ICU during hospital stay, duration from hospital admission to the transfer to the ICU, and the total length of hospital stay were recorded. RESULTS: A total of 175 patients were included in the study and among these, 64 patients formed the severe illness group whereas 111 comprised the non-severe illness group. There was statistically significant difference in terms of galectin-3 levels between groups (1.07 ± 0.75 vs 0.484 ± 0.317, p < 0.0001, respectively). Our results showed that galectin-3, IL-6 and CRP levels at admission were independent risk factors associated with transfer to the ICU whereas only galectin-3 was an independent factor for the need for advanced ventilatory support. Also, galectin-3 and IL-6 were independent risk factors related to in-hospital mortality. CONCLUSION: In conclusion, our results indicated that galectin-3 had moderate power in outlining disease severity and the need for ICU transfer throughout the clinical course in COVID-19.


Assuntos
COVID-19 , Galectinas/sangue , Proteínas Sanguíneas , Estudos Transversais , Galectina 3 , Hospitalização , Humanos , Unidades de Terapia Intensiva , Interleucina-6 , Prognóstico , Estudos Prospectivos , Estudos Retrospectivos
2.
Pediatr Nephrol ; 33(4): 611-613, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-28721513

RESUMO

Genitourinary system tuberculosis (GUTB) is a chronic granulomatous infection in which tuberculous bacilli affect one or more organs in the genitourinary system. In this report, an unusual presentation of miliary tuberculosis was presented as GUTB. A 15-year-old girl presented with complaints of severe abdominal pain and dysuria. Abdominal examination showed tenderness and defense. Pyuria and microscopic hematuria were observed. Acute abdominal causes could not be excluded through abdominal ultrasound. On abdominal computed tomography, a necrotic lesion was detected in the right kidney. Acid-fast bacilli were detected in the urine. Quartet anti-tuberculosis therapy was started. After treatment, static renal scintigraphy with 99mTc-dimer captosuccinic acid and single-photon emission CT imaging showed parenchymal injury. In any suspected patient, voiding symptoms, abdominal or flank pain, sterile pyuria, and hematuria should be kept in mind as the presenting manifestations of GUTB in the differential diagnosis.


Assuntos
Piúria/etiologia , Tuberculose Urogenital/diagnóstico , Infecções Urinárias/diagnóstico , Adolescente , Antituberculosos/uso terapêutico , Diagnóstico Diferencial , Feminino , Humanos , Rim/diagnóstico por imagem , Rim/patologia , Mycobacterium tuberculosis/isolamento & purificação , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Tuberculose Urogenital/tratamento farmacológico , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia , Urina/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...